Smartphone app aims to boost Well-Being after colorectal cancer
NCT ID NCT07158671
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This trial tests whether a mobile health (mHealth) program can improve quality of life for colorectal cancer survivors who have finished active treatment. About 210 Vietnamese-speaking adults will either use the app daily and receive biweekly phone calls for 3 months, or get usual care. The study measures changes in distress, depression, anxiety, fatigue, and bowel function.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
mHealth survivorship program (mobile app and biweekly phone consultations)
What this could lead to
If it works, this could offer a simple, scalable way to help colorectal cancer survivors feel better emotionally and physically after treatment.
What could go wrong
This is a small, early-stage trial with no blinding, so results may be influenced by participants' expectations. The program requires daily app use, which may be hard for some to maintain.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER (DIAGNOSIS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••